Intravitreal Bevacizumab for Diabetic Retinopathy

Clinical trial NCT00600262 · TERMINATED

Trial details

NCT number: NCT00600262
Sponsor: Asociación para Evitar la Ceguera en México
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Severe Nonproliferative Proliferative Diabetic Retinopathy Active Photocoagulated Diabetic Retinopathy

Start date: 2005-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.